Trial data transparency

In this week’s bmj ‘Head to Head’ feature, Ben Goldacre, AllTrials.net campaigner, and John Castellani, president and chief executive officer of the Pharmaceutical Research and Manufacturers of America, make the case for change (doi:10.1136/bmj.f1880) and for the status quo, respectively (doi:10.1136/bmj.f1881), as part of the bmj campaign for greater trial data transparency (www.bmj.com/open-data). See Editor’s Choice, US Editor’s Choice, The Shifting Debate on Trial Data Transparency – Edward Davies, US News and Features Editor. http://www.bmj.com/content/347/bmj.f4485

Advertisements

About bmitzi

Medical writer, author, artist. Cancer campaigner. Aiming always to improve health services and bring compassion into health care.
This entry was posted in Campaigns, clinical trials, Compassion in healthcare, patient safety and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s